DAYTRANA

LOE Approaching

methylphenidate

NDATRANSDERMALFILM, EXTENDED RELEASE
Approved
Apr 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

stimulant. Its mode of therapeutic action in ADHD is not known.

Pharmacologic Class:

Central Nervous System Stimulant

Clinical Trials (5)

NCT05669170Phase 2Not Yet Recruiting

Methylphenidate for Apathy in Veterans With Parkinson's Disease

Started Jan 2024
60 enrolled
Parkinson DiseaseApathy
NCT04132557N/ACompleted

A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

Started Oct 2019
430,000 enrolled
Attention Deficit Disorder With Hyperactivity
NCT03536390Phase 4Withdrawn

A 6-week Study to Evaluate the Safety and Efficacy of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD

Started Sep 2018
0
Attention Deficit Hyperactivity Disorder
NCT02730572N/ACompleted

Concerta (Methylphenidate) -To-Generic Switch Study

Started Sep 2015
1,464 enrolled
Attention Deficit Disorder With Hyperactivity
NCT02315651N/AUnknown

Efficacy of Combined Treatment With CoQ10 and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder

Started Jan 2015
60 enrolled
Attention Deficit Hyperactivity Disorder